Csaba P Kovesdy MD Fred Hatch Professor of Medicine Director, Clinical Outcomes and Clinical Trials Program Division of Nephrology, University of Tennessee Health Science Center Nephrology Section Chief, Memphis VA Medical Center Memphis TN, 38163

Low Dose Aspirin May Be Beneficial in Chronic Kidney Disease Patients

MedicalResearch.com Interview with:

Csaba P Kovesdy MD Fred Hatch Professor of Medicine Director, Clinical Outcomes and Clinical Trials Program Division of Nephrology, University of Tennessee Health Science Center Nephrology Section Chief, Memphis VA Medical Center Memphis TN, 38163

Dr. Csaba P. Kovesdy

Csaba P Kovesdy MD FASN
Fred Hatch Professor of Medicine
Director, Clinical Outcomes and Clinical Trials Program
Division of Nephrology, University of Tennessee Health Science Center
Nephrology Section Chief, Memphis VA Medical Center
Memphis TN, 38163 

MedicalResearch.com: What is the background for this study?

Response: Microinflammation may be a mechanism contributing to adverse outcomes in patients with chronic kidney disease (CKD). Low dose aspirin (ASA) is usually used as an antiplatelet agent for cardiovascular indications, but may also have beneficial effects on kidney function by reducing microinflammation. 

MedicalResearch.com: What are the main findings?

Response: We found an association between long-term aspirin and lower risk of a composite renal outcome and mortality in a single center cohort of patients with CKD.

MedicalResearch.com: What should readers take away from your report?

Response: Aspirin may have beneficial effects in CKD beyond prevention of cardiovascular events. 

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: Our results are hypothesis generating and will need to be replicated in larger and more diverse cohorts and potentially in future clinical trials, before we can recommend aspirin for renoprotection.

Citation:

American Society of Nephrology (ASN) 2021 Kidney Week Poster

Association of Long-Term Aspirin Use with Progression of Kidney Disease
Author(s):  Jun Ling Lu1; Fridtjof Thomas1; Keiichi Sumida1; Waleed Hassan1; Csaba P. Kovesdy1
1The University of Tennessee Health Science Center, Memphis, Tennessee, United States

Subscribe box:

JOIN OUR EMAIL LIST

We respect your privacy and will never share your details.

Nov 8, 2021 @ 10:42 am 

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.